Bli medlem
Bli medlem

Du är här


Vistin Pharma ASA: Invitation to Q3 2020 conference call

Oslo, Norway, 26 October 2020

Vistin Pharma ASA will release its third quarter 2020 results on Friday 30 October 2020. Vistin Pharma will host a conference call for all shareholders and interested parties on Friday 30 October at 08:30 CET. There will be a Q&A session following the management discussion.

The conference call will be held in Norwegian.

The third quarter conference call will be available via web and audio through the following access points:

Telephone conference:

Dial in details, Participants:
Confirmation Code:........ 9184755
International Dial-In:........ +44 (0) 2071 928338
Norway, Oslo:................ +47 21563015
United States, New York: +1 6467413167



For further information, please contact:

Alexander Karlsen
+47 97053621

About Vistin Pharma |

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.

Författare Vistin Pharma ASA

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.